MedTrace Logo

A Clinical Study of Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for the Treatment of Premature Ovarian Insufficiency

NCT07510139 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-04-03

No results posted yet for this study

Summary

Clinical Study of Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Premature Ovarian Insufficiency

Conditions

  • Premature Ovarian Insufficiency

Interventions

BIOLOGICAL

YT023

YT023 is administered via in situ (intra-ovarian) injection

OTHER

Control Arm (Conventional Therapy)

The control group will receive assisted reproductive therapy in accordance with the standard of care at the study site

Sponsors & Collaborators

  • Shanghai Yuantian Biotechnology Co., Ltd

    collaborator UNKNOWN

  • International Peace Maternity and Child Health Hospital

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
39 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-20
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07510139 on ClinicalTrials.gov